Cargando…
Identification of Repurposable Drugs and Adverse Drug Reactions for Various Courses of COVID-19 Based on Single-Cell RNA Sequencing Data
Coronavirus disease 2019 (COVID-19) has impacted almost every part of human life worldwide, posing a massive threat to human health. There is no specific drug for COVID-19, highlighting the urgent need for the development of effective therapeutics. To identify potentially repurposable drugs, we empl...
Autores principales: | Wang, Zhihan, Guo, Kai, Gao, Pan, Pu, Qinqin, Wu, Min, Li, Changlong, Hur, Junguk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cornell University
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724679/ https://www.ncbi.nlm.nih.gov/pubmed/33299905 |
Ejemplares similares
-
Repurposable drugs for SARS-CoV-2 and influenza sepsis with scRNA-seq data targeting post-transcription modifications
por: Wang, Zhihan, et al.
Publicado: (2021) -
Microbial and genetic-based framework identifies drug targets in inflammatory bowel disease
por: Wang, Zhihan, et al.
Publicado: (2021) -
Machine learning-based identification and rule-based normalization of adverse drug reactions in drug labels
por: Tiftikci, Mert, et al.
Publicado: (2019) -
Exploration of the Anti-Inflammatory Drug Space Through Network Pharmacology: Applications for Drug Repurposing
por: de Anda-Jáuregui, Guillermo, et al.
Publicado: (2018) -
Ontology-based literature mining and class effect analysis of adverse drug reactions associated with neuropathy-inducing drugs
por: Hur, Junguk, et al.
Publicado: (2018)